SFI
TYRA icon

Susquehanna Fundamental Investments’s Tyra Biosciences TYRA Stock Holding History

Susquehanna Fundamental Investments’s Portfolio TYRA Stock Details TYRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-39,093
Closed -$543K – 1237
2024
Q4 		$543K Buy
+39,093
New +$709K 0.01% 844

Other funds holding TYRA

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
CPX
Canaan Partners XI Menlo Park, California $127M AUM 217.49% 1-Year Est. Return
APMC
Alta Partners Management Company Jackson, Wyoming $127M AUM 230.85% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Susquehanna Fundamental Investments's TYRA Position: Q1 2025 in Review

Susquehanna Fundamental Investments sold out of Tyra Biosciences (TYRA) in Q1 2025, closing a stake of 39,093 shares — an estimated $543K sold.

Susquehanna Fundamental Investments first reported a position in TYRA in Q4 2024 and held it in 1 quarter. The position peaked at $543K in Q4 2024. 117 funds tracked by Wall St. Rank hold TYRA as of Q1 2025.

  • Susquehanna Fundamental Investments reported no remaining Tyra Biosciences position as of Q1 2025 after selling out during the quarter.
  • Susquehanna Fundamental Investments sold 39,093 Tyra Biosciences shares in Q1 2025, an estimated $543K.
  • Susquehanna Fundamental Investments first reported a position in Tyra Biosciences in Q4 2024 and held it in 1 quarter.
  • Susquehanna Fundamental Investments's Tyra Biosciences position peaked at $543K in Q4 2024.
  • 117 funds tracked by Wall St. Rank held Tyra Biosciences as of Q1 2025.

Based on Susquehanna Fundamental Investments's 13F filing for Q1 2025, filed 14 May 2025.